252015-00-2 Usage
Uses
Used in Pharmaceutical Industry:
(2R)-N-(2-chloro-4-((4-(methylsulfonyl)phenyl)sulfinyl)phenyl)-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide is used as a potential therapeutic agent for various medical conditions due to its anti-inflammatory and antibacterial properties. Its unique chemical structure and functional groups may contribute to its efficacy in treating specific diseases and disorders.
Used in Drug Development Research:
(2R)-N-(2-chloro-4-((4-(methylsulfonyl)phenyl)sulfinyl)phenyl)-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide is used as a promising candidate for drug development research, given its potential pharmacological activities and the possibility of modulating biological pathways. Further research and development may lead to the discovery of new treatments and therapies for various medical conditions.
Used in Chemical Reactivity Studies:
(2R)-N-(2-chloro-4-((4-(methylsulfonyl)phenyl)sulfinyl)phenyl)-3,3,3-trifluoro-2-hydroxy-2-methylpropanamide is used in studies related to chemical reactivity, particularly due to the presence of chloro and trifluoro groups. Understanding the reactivity of these groups can provide insights into the compound's potential applications and interactions with biological molecules.
Check Digit Verification of cas no
The CAS Registry Mumber 252015-00-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,5,2,0,1 and 5 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 252015-00:
(8*2)+(7*5)+(6*2)+(5*0)+(4*1)+(3*5)+(2*0)+(1*0)=82
82 % 10 = 2
So 252015-00-2 is a valid CAS Registry Number.
252015-00-2Relevant articles and documents
Use of compounds for the elevation of pyruvate dehydrogenase activity
-
, (2008/06/13)
The use of compounds of the formula (I), and salts thereof; and pharmaceutically acceptable in vivo cleavable prodrugs of said compound of formula (I); and pharmaceutically acceptable salts of said compound or said prodrugs: wherein: Ring C is phenyl or a carbon linked heteroaryl ring substituted as defmed within; R1is an ortho substituent as defined within; n is 1 or 2; A—B is a linking group as defined within; R2and R3are as defined within; R4is hydroxy, hydrogen, halo, amino or methyl; in the manufacture of a medicament for use in the elevation of PDH activity in warm-blooded animals such as humans is described. Pharmaceutical compositions, methods and processes for preparation of compounds of formula (I) are also described.
